Features Screener Stocks Charts
Sign In Sign Up

Dr Reddy Financial Statements

NSE: DRREDDY | BSE: 500124 | PHARMACEUTICALS

Showing 5 of 10 years of data. Sign up free for the full 10 years of history.

View Plans

Dr Reddy (DRREDDY) reported revenue of ₹337.41B in FY2025 with net income of ₹57.25B. Total assets stood at ₹494.27B and free cash flow was ₹18.92B.

Dr Reddy Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Revenue 190.48B 220.30B 257.25B 289.05B 337.41B
Cost of Rev. -60.79B -74.42B -76.58B -82.09B -99.80B
Gross Profit 129.69B 145.87B 180.68B 206.97B 237.61B
SGA -84.22B -103.35B -106.63B -118.69B -141.17B
Op. Income 26.41B 30.87B 61.54B 73.57B 79.41B
PBT 28.36B 29.91B 60.12B 71.86B 76.58B
Net Income 19.52B 21.83B 45.07B 55.78B 57.25B
Dil. Shares 830.41M 831.69M 831.94M 833.54M 834.18M
Diluted EPS 23.50 26.24 54.18 66.92 67.79

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Dr Reddy's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Dr Reddy Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Curr. assets 145.50B 177.82B 204.26B 248.05B 250.18B
Non-curr. assets 120.67B 119.65B 118.60B 140.59B 244.09B
Total assets 266.17B 297.47B 322.85B 388.64B 494.27B
Curr. liabilities 81.04B 97.66B 85.72B 95.88B 130.34B
Non-curr. liab. 8.71B 7.69B 4.27B 10.21B 24.65B
Total liabilities 89.75B 105.35B 89.99B 106.09B 154.99B
Total equity 176.42B 192.12B 232.86B 282.55B 339.27B
Total liab. & eq. 266.17B 297.47B 322.85B 388.64B 494.27B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Dr Reddy's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Dr Reddy Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Net Income 28.84B 30.61B 60.49B 72.01B 76.80B
Operating CF 35.70M 28.11B 58.87B 45.43B 46.43B
Capex -9.74B -14.66B -11.32B -16.40B -27.50B
Investing CF -22.66B -26.39B -41.37B -40.28B -58.08B
Dividend Paid -4.15B -4.15B -4.98B -6.65B -6.66B
Financing CF -298.00M -2.42B -26.86B -3.76B 18.91B
Cash (start) 1.96B 14.82B 14.85B 5.78B 7.11B
Cash (end) 14.82B 14.85B 5.78B 7.11B 14.59B
FCF -9.71B 13.45B 47.55B 29.03B 18.92B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Dr Reddy's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025

Related Stocks